KRAS and lung cancer: Evidence supporting these mechanistic scenarios includes, the identification of a SNP associated with increased risk of lung cancer and ovarian cancer, that alters a let-7 miRNA binding site in the 3'UTR of the KRAS transcript [17, 18].